MustGrow receives first development milestone payment from Bayer under licensing deal

Reuters2026/08/21 11:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

MustGrow received a first development milestone payment from Bayer under a December 2023 license and collaboration agreement.
Deal grants Bayer rights for soil applications of MustGrow’s mustard-based biocontrol technology across Europe, the Middle East, and Africa.
Further milestone payments depend on additional development achievements; royalties and manufacturing fees would begin if commercial sales start.
MustGrow estimates total upfront, milestones, and Bayer-funded development work could reach USD 35-40 million over 5-7 years.
Bayer will lead regulatory filings and market development in the territory; MustGrow expects minimal incremental costs beyond supplying test product.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MustGrow Biologics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608210700NEWSFILECNPR____20260821_310671_1) on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

MustGrow receives first development milestone payment from Bayer under licensing deal

You may also like

Crypto prices